Kiora Pharmaceuticals (KPRX) to Release Earnings on Monday

Kiora Pharmaceuticals (NASDAQ:KPRX) is projected to announce its earnings results before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.64) per share and revenue of $0.75 million for the quarter.

Kiora Pharmaceuticals Stock Up 3.5 %

NASDAQ:KPRX opened at $3.29 on Friday. Kiora Pharmaceuticals has a twelve month low of $2.91 and a twelve month high of $6.48. The business has a 50 day moving average price of $3.51 and a two-hundred day moving average price of $3.49.

Kiora Pharmaceuticals Company Profile

Kiora Pharmaceuticals, Inc, a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1b clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases.